Zacks Investment Research
01 Oct 2026, 09:36 UTC · 1h ago
Verdict
Headline takes no side. We score PGEN +0.90 across three claims — strongly bullish.
+0.90strongly bullish
More positive than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 0 new · 3 priced in
Precigen is expected to report quarterly revenues of $76.43 million, a 2517.5% increase year-over-year.
Priced inanalysis of upcoming report expectations
More positive than 99% of claims this week
Precigen's expected quarterly earnings are $0.09 per share, representing a year-over-year increase of 181.8%.
Priced in
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
So whatThe shift to positive EPS suggests the company may reach a break-even inflection point this quarter.
More positive than 93% of claims this week
Precigen shares closed at $8.56 after a 6.3% increase in the last trading session.
Priced inreport of last trading session close
So whatThe current price represents a 17.4% gain over the last four weeks.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 96% of ticker scores this week
Shares soared 6.3% due to growing investor confidence in sales of its FDA-approved drug Papzimeos and strong expected revenue growth.
Near neutral — 91% of ticker scores this week are stronger
The stock closed slightly higher but has returned -9.1% over the past month with a 'Hold' rating.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Business Wire
2h ago
—
PGEN hasn't traded since this ran. Last close $8.56 (Sep 30); the reaction starts at the next open.
PGEN chart →
